🇺🇸 FDA
Drug

etodolac

Brand: LODINE

approved

Quick answer

etodolac (LODINE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

Key facts

INN
etodolac
Brand
LODINE
Route
ORAL
Formulation
TABLET, EXTENDED RELEASE
Originator
Amneal Pharmaceuticals

Related patents

patent

US 7211599

Use of etodolac to treat hyperplasia

Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7105560

Use of etodolac in the treatment of multiple myeloma

Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7105561

Use of etodolac for the treatment of prostate cancer

Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 6545034

Use of etodolac for the treatment of chronic lymphocytic leukemia

Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is etodolac?

etodolac (LODINE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for etodolac?

LODINE is a marketed brand name for etodolac. Check FDA Drugs@FDA for the current US label holder.